2025 Editorial Calendar
Content themes:
- Bio/Pharma Industry Radar: Top trends impacting the global bio/pharmaceutical industry and its manufacturing value chain.
- The CDMO/CMO & Suppliers Report: Key developments from CDMOs/CMOs and suppliers, along with trends shaping outsourcing and pharma ingredients supply.
- From the Executive Suite: Industry leaders share their perspectives on drug development, commercialization, manufacturing, and supply.
- Manufacturing & Supply Lines: The latest developments impacting the industry’s manufacturing value chain, from raw materials to drug substances (small molecules & biologics) to drug products to packaging.
- Special Reports: Special coverage of DCAT webinars and education programs, including programs from DCAT Week as well as other industry-focused reports.
Editorial Questions or questions about the 2024 Editorial Calendar? Contact Patricia Van Arnum, DCAT’s Editorial Director at pvanarnum@dcat.org, Tel: +1-(856)-388-2964
DCAT Value Chain Insights 2025 Editorial Calendar: January-December 2025
| Issue Date |
Content Focus |
| January 3 |
Bio/Pharma Industry Radar: Outlook for 2025 Experts weigh in on the top issues impacting the bio/pharma industry in 2025. |
| January 10 |
The CDMO/CMO & Suppliers Report: The Year Ahead Market outlook for bio/pharmaceutical outsourcing in 2025. |
| January 17 |
From the Executive Suite: Small-Molecule APIs Industry roundtable of senior executives on the key forces shaping the market for small-molecules drugs. |
| January 24 |
Manufacturing and Supply Lines: Biologics Supply–demand fundamentals and trends for biologic-based drugs. |
| January 31 |
Special Report: New Drug Approvals The major trends in new drug approvals, including the mix between small molecules and biologics. |
| February 7 |
Bio/Pharma Industry Radar: Blockbuster Potential The leading contenders from the industry’s pipeline expected to launch in 2025 and projected for blockbuster status. |
| February 14 |
The CDMO/CMO & Suppliers Report: Parenteral Drugs Analysis of manufacturing capacity in sterile manufacturing and aseptic fill–finish. |
| February 21 |
Special Report: DCAT Week 2025 Preview A preview of the education programs at DCAT Week 2025 (March 17 to March 20, 2025). |
| February 28 |
Special Report: DCAT Week 2025 Preview A preview of the education programs at DCAT Week 2025 (March 17 to March 20, 2025). |
| March 7 |
No issue DCAT Week 2025 (March 17 to March 20, 2025). |
| March 14 |
No issue DCAT Week 2025 (March 17 to March 20, 2025). |
| March 21 |
No issue DCAT Week 2025 (March 17 to March 20, 2025). |
| March 28 |
The CDMO/CMO & Suppliers Report: Sustainability Key initiatives from CDMOs/CMOs in advancing environmental performance, including greenhouse gas reduction. |
| April 4 |
Special Report: The Newsmakers: DCAT Week 2025 in Review Roundup from the DCAT Member Company Announcement Forum at DCAT Week 2025. |
| April 11 |
Special Report: DCAT Week 2025 in Review Key takeaways from the education programs at DCAT Week 2025. |
| April 18 |
From the Executive Suite: Fine Chemicals & Pharma Ingredients Executive insights on the major forces impacting global supply chains for fine chemicals and pharma ingredients. |
| April 25 |
Manufacturing & Supply Lines: Biomanufacturing The latest roundup of expansions among CDMOs/CMOs and bio/pharma companies in biomanufacturing. |
| May 2 |
Bio/Pharma’s Industry Radar: Orphan Drugs Market overview of the top-selling and blockbuster contenders for rare-disease drugs. |
| May 9 |
The CDMO/CMO & Suppliers Report: Peptides & Oligonucleotides The latest expansions among CDMOs/CMOs in peptides and oliogonucleotides and key market trends. |
| May 16 |
From the Executive Suite: Emerging Pharma & Manufacturing Senior executives share perspectives on manufacturing & supply. |
| May 23 |
No issue |
| May 30 |
Manufacturing & Supply Lines: High-Potency Manufacturing Market overview and expansions in high-potency manufacturing for drug substances and drug products. |
| June 6 |
Bio/Pharma Industry Radar: Generics & Biosimilars Market outlook for generic drugs and biosimlars. |
| June 13 |
The CDMO/CMO & Suppliers Report: Injectables The latest developments and manufacturing expansions for injectable drugs. |
| June 20 |
From the Executive Suite: Drug Products Insights from senior executives on key trends shaping development and manufacturing of drug products. |
| June 27 |
Manufacturing & Supply Lines: Cell & Gene Therapies Market overview and capacity analysis for cell and gene therapies. |
| July 4 |
No issue |
| July 11 |
The CDMO/CMO & Suppliers Report: Mid-Year Review The key trends and developments impacting the CDMO/CMO sector thus far in 2025. |
| July 18 |
From the Executive Suite: The Supply Chain Leaders Ranking and analysis of the top supply-chain organizations. |
| July 25 |
Manufacturing & Supply Lines: Chemicals & Raw Materials The latest trends and issues impacting chemical supply chains and raw materials sourcing. |
| August 1 |
Bio/Pharma Industry Radar: Top Mergers & Acquisitions Analysis of the top deals in the bio/pharma industry thus far in 2025. |
| August 8 |
The CDMO/CMO & Suppliers Report: Drug Delivery Key technology & market advances from CDMOs/CMOs and excipient suppliers, including for lipid nanoparticles. |
| August 15 |
From the Executive Suite: Digitalization & Supply Chains A future look on how digital transformation, including artificial intelligence, may shape bio/pharma supply chains. |
| August 22 |
Manufacturing & Supply Lines: Big Pharma’s Investments Capital investment and the latest manufacturing expansions among the bio/pharmaceutical majors. |
| August 29 |
No issue |
| September 5 |
Bio/Pharma Industry Radar: Small-Molecule APIs Analysis of the top-selling small-molecule drugs and pipeline contenders. |
| September 12 |
The CDMO/CMO & Suppliers Report: Drug Products & Excipients Market and technology trends in formulation development and drug-product manufacturing. |
| September 19 |
From the Executive Suite: Continuous Manufacturing Manufacturing executives discuss the near-term and future role of continuous manufacturing in the bio/pharma industry. |
| September 26 |
Manufacturing & Supply Lines: Biomanufacturing The latest expansions and trends in contract biomanufacturing. |
| October 3 |
Bio/Pharma Industry Radar: The Pipeline Leaders Analysts weigh in on leading late-stage drug candidates with strong market potential. |
| October 10 |
The CDMO/CMO and Suppliers Report: Antibody Drug Conjugates Expansions and trends shaping the contract manufacturing market for antibody drug conjugates. |
| October 17 |
From the Executive Suite: Small-Molecule Drugs Latest insights from senior executives on key trends impacting product development and manufacturing for small-molecule drugs. |
| October 24 |
Manufacturing & Supply Lines: RNA/mRNA Manufacturing Roundup of latest product and manufacturing for RNA/mRNA therapeutics and vaccines. |
| October 31 |
Special Report: The Dealmakers: Big Pharma & Emerging Pharma Analysis of the top partnering deals between the bio/pharma majors and Emerging Pharma thus far in 2025. |
| November 7 |
Bio/Pharma Industry Radar: Biologics Analysis of the top-selling biologic-based drugs and leading pipeline contenders. |
| November 14 |
The CDMO/CMO & Suppliers Report: Small-Molecule APIs Key developments impacting the supply of small-molecule active pharmaceutical ingredients and intermediates. |
| November 21 |
From the Executive Suite: The Innovation Leaders Bio/pharma companies and executives making the key moves thus far in 2025. |
| November 28 |
No issue |
| December 5 |
Bio/Pharma Industry Radar: The Year in Review A look at the top 10 developments in the bio/pharma industry in 2025. |
| December 12 |
The CDMO/CMO & Suppliers Report: The Movers & Shakers of 2025 A look at the top moves from CDMOs/CMOs in 2025. |
| December 19 |
No issue. |
| December 26 |
No issue. |
